• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性乙型肝炎病毒感染肝组织中白细胞介素-32 的表达增加。

Increased interleukin-32 expression in chronic hepatitis B virus-infected liver.

机构信息

Department of Infectious Diseases, The 3rd Affiliated Hospital, Sun Yat-Sen University, No.600, Tianhe Road, Guangzhou 510630, China.

出版信息

J Infect. 2012 Oct;65(4):336-42. doi: 10.1016/j.jinf.2012.05.009. Epub 2012 Jun 8.

DOI:10.1016/j.jinf.2012.05.009
PMID:22687868
Abstract

OBJECTIVES

The role of interleukin-32 (IL-32) in chronic hepatitis B (CHB) remains unclear. In order to identify the role of IL-32 in CHB, we detected the expression levels of IL-32 in liver samples of CHB patients and analyzed the correlation between IL-32 and liver inflammation/fibrosis.

METHODS

Real-time PCR and immunohistochemistry were used to detect the expression levels of IL-32 in liver tissues of patients with CHB. The correlation between hepatic IL-32 expression and the severity of liver inflammation/fibrosis was assessed using Spearman's correlation.

RESULTS

Hepatic IL-32 expression was increased in CHB patients and increased with the severity of liver inflammation/fibrosis. Moreover, hepatic IL-32 expression was significantly positively correlated with serum ALT level and negatively related with serum ALB level.

CONCLUSIONS

Our results suggest that IL-32 could be implicated in HBV-related liver inflammation/fibrosis. We believe that IL-32 might play important roles in the pathogenesis of CHB.

摘要

目的

白细胞介素 32(IL-32)在慢性乙型肝炎(CHB)中的作用尚不清楚。为了确定 IL-32 在 CHB 中的作用,我们检测了 CHB 患者肝组织中 IL-32 的表达水平,并分析了 IL-32 与肝炎症/纤维化之间的相关性。

方法

采用实时 PCR 和免疫组织化学法检测 CHB 患者肝组织中 IL-32 的表达水平。采用 Spearman 相关分析评估肝内 IL-32 表达与肝炎症/纤维化严重程度的相关性。

结果

CHB 患者肝内 IL-32 表达增加,且随着肝炎症/纤维化的严重程度增加而增加。此外,肝内 IL-32 表达与血清 ALT 水平呈显著正相关,与血清 ALB 水平呈负相关。

结论

我们的结果表明,IL-32 可能参与了 HBV 相关的肝炎症/纤维化。我们认为,IL-32 可能在 CHB 的发病机制中发挥重要作用。

相似文献

1
Increased interleukin-32 expression in chronic hepatitis B virus-infected liver.慢性乙型肝炎病毒感染肝组织中白细胞介素-32 的表达增加。
J Infect. 2012 Oct;65(4):336-42. doi: 10.1016/j.jinf.2012.05.009. Epub 2012 Jun 8.
2
Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.在印度尼西亚,血清 ALT 低于正常值上限的 2 倍但 HBV-DNA 水平较高的慢性乙型肝炎患者中存在显著的肝脏组织病理学变化。
J Dig Dis. 2011 Dec;12(6):476-80. doi: 10.1111/j.1751-2980.2011.00540.x.
3
[Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].[慢性乙型肝炎合并肝脂肪变性的临床及病理特征分析]
Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):817-20.
4
There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume.在肝组织细胞体积相同的情况下,HBeAg 阳性和 HBeAg 阴性慢性乙型肝炎的血清 HBV DNA 水平在相同的肝组织学坏死炎症分级之间没有差异,但在 1、2、3 和 4 级之间存在差异。
J Viral Hepat. 2011 Sep;18(9):637-45. doi: 10.1111/j.1365-2893.2011.01444.x. Epub 2011 Mar 24.
5
[Expression of interleukin-17 in hepatitis B related liver fibrosis].[白细胞介素-17在乙型肝炎相关肝纤维化中的表达]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Feb;25(2):133-5.
6
Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B.在慢性乙型肝炎中,血清脂联素水平随肝纤维化进展而升高,随纤维化程度减轻而下降。
J Hepatol. 2007 Aug;47(2):191-202. doi: 10.1016/j.jhep.2007.02.023. Epub 2007 Apr 12.
7
[Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].[Hfgl2/纤维白细胞介素在肝脏及外周血单个核细胞(PBMC)中的表达及其与疾病严重程度的相关性]
Zhonghua Gan Zang Bing Za Zhi. 2004 Jul;12(7):385-8.
8
IL-17 expression is correlated with hepatitis B‑related liver diseases and fibrosis.IL-17 的表达与乙型肝炎相关的肝脏疾病和纤维化相关。
Int J Mol Med. 2011 Mar;27(3):385-92. doi: 10.3892/ijmm.2011.594. Epub 2011 Jan 10.
9
Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis.Th17 细胞增加导致乙型肝炎病毒相关性肝硬化患者疾病进展。
J Viral Hepat. 2012 Jun;19(6):396-403. doi: 10.1111/j.1365-2893.2011.01561.x. Epub 2012 Mar 28.
10
Elevated TGF-β1/IL-31 Pathway Is Associated with the Disease Severity of Hepatitis B Virus-Related Liver Cirrhosis.转化生长因子-β1/白细胞介素-31通路升高与乙型肝炎病毒相关性肝硬化的疾病严重程度相关。
Viral Immunol. 2015 May;28(4):209-16. doi: 10.1089/vim.2014.0142. Epub 2015 Feb 24.

引用本文的文献

1
Lower Plasma IL-32 Levels Linked to Better Survival in Sepsis.血浆白细胞介素-32水平较低与脓毒症患者更好的生存率相关。
Biomedicines. 2025 Mar 19;13(3):750. doi: 10.3390/biomedicines13030750.
2
Association Between Serum Interleukin-32 Level and Disease Status in Cases with Neuromyelitis Optica Spectrum Disorders.视神经脊髓炎谱系障碍患者血清白细胞介素-32水平与疾病状态的关联
J Inflamm Res. 2024 Aug 26;17:5645-5652. doi: 10.2147/JIR.S476435. eCollection 2024.
3
Saturated Fat-Mediated Upregulation of IL-32 and CCL20 in Hepatocytes Contributes to Higher Expression of These Fibrosis-Driving Molecules in MASLD.
饱和脂肪介导的肝细胞中 IL-32 和 CCL20 的上调导致 MASLD 中这些纤维化驱动分子的更高表达。
Int J Mol Sci. 2023 Aug 25;24(17):13222. doi: 10.3390/ijms241713222.
4
Circulating and inducible IL-32α in chronic hepatitis C virus infection.慢性丙型肝炎病毒感染中循环及诱导性IL-32α
Can Liver J. 2019 Feb 25;2(1):23-30. doi: 10.3138/canlivj.2018-0003. eCollection 2019 Winter.
5
A Critical Overview of Interleukin 32 in Leishmaniases.白细胞介素 32 在利什曼病中的研究进展综述
Front Immunol. 2022 Mar 3;13:849340. doi: 10.3389/fimmu.2022.849340. eCollection 2022.
6
Interleukin-32 in the Control of Acute Experimental Chagas Disease.白细胞介素-32 在急性实验性恰加斯病中的作用。
J Immunol Res. 2022 Jan 20;2022:7070301. doi: 10.1155/2022/7070301. eCollection 2022.
7
Evaluation of interleukin-32 and cyclooxygenase-2 expression in HAM/TSP patients and HTLV-1 asymptomatic carriers.人毛细胞性白血病/热带痉挛性截瘫患者及人类嗜T淋巴细胞病毒1型无症状携带者中白细胞介素-32和环氧化酶-2表达的评估。
Iran J Basic Med Sci. 2021 Jul;24(7):992-996. doi: 10.22038/ijbms.2021.50821.11569.
8
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker.肝脏转录组学强调白细胞介素 32 作为新型非酒精性脂肪性肝病相关细胞因子和候选生物标志物。
Gut. 2020 Oct;69(10):1855-1866. doi: 10.1136/gutjnl-2019-319226. Epub 2020 Jan 30.
9
Interleukin-32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance.白细胞介素-32促成人类非酒精性脂肪性肝病和胰岛素抵抗。
Hepatol Commun. 2019 Jul 19;3(9):1205-1220. doi: 10.1002/hep4.1396. eCollection 2019 Sep.
10
Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus.细胞内白细胞介素-32γ介导细胞因子对乙型肝炎病毒的抗病毒活性。
Nat Commun. 2018 Aug 16;9(1):3284. doi: 10.1038/s41467-018-05782-5.